Physician profile
Beth A Sweeney
NPI 1841290335
$1,420.50
in general payments reported to CMS, 2019-2025
18 companies · $19.32 in 2025
The $19.32 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $660 · 2022: $492 · 2023: $126 · 2024: $123 · 2025: $19.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $277.74 | 2021-2024 | Taltz, Ebglyss |
| Abbvie INC. | $275.43 | 2021-2023 | |
| Amgen INC. | $223.04 | 2021 | |
| Novo Nordisk INC | $190.90 | 2021-2023 | Ozempic, Rybelsus |
| Biohaven Pharmaceuticals, INC. | $100.50 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $64.63 | 2021-2023 | Abilify Maintena, Rexulti |
| Abbott Laboratories | $61.11 | 2021-2023 | Freestyle Libre 3 |
| Dexcom, INC. | $56.25 | 2022 | |
| Merck Sharp & Dohme LLC | $26.71 | 2021-2022 | |
| Astellas Pharma US INC | $21.47 | 2021 | |
| Mallinckrodt Hospital Products INC. | $19.32 | 2025 | Acthar |
| Alkermes, INC. | $16.85 | 2022 | |
| Sanofi Pasteur INC. | $16.75 | 2022 | |
| Amarin Pharma, INC. | $16.66 | 2021 | |
| Organon LLC | $15.13 | 2023 | Nexplanon |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.89 | 2022 | |
| Vanda Pharmaceuticals INC. | $13.07 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.